235 related articles for article (PubMed ID: 12453012)
1. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
2. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
3. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
4. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Hengge UR; Cusini M
Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
7. Imiquimod as an immune response modulator in infectious conditions.
Skinner RB
Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
[TBL] [Abstract][Full Text] [Related]
8. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod.
Slade HB
Eur J Dermatol; 1998; 8(7 Suppl):13-6; discussion 20-2. PubMed ID: 10387958
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod (Aldara): modifying the immune response.
Rudy SJ
Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
11. Immune response modification: imiquimod.
Tyring S
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S11-3. PubMed ID: 9842095
[TBL] [Abstract][Full Text] [Related]
12. Viral and nonviral uses of imiquimod: a review.
Gupta AK; Cherman AM; Tyring SK
J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
14. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
Schaen L; Mercurio MG
Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
[TBL] [Abstract][Full Text] [Related]
15. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
16. Imiqimod in clinical practice.
Trofatter KF
Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
[TBL] [Abstract][Full Text] [Related]
17. The imidazoquinolines and their place in the therapy of cutaneous disease.
Smith KJ; Hamza S; Skelton H
Expert Opin Pharmacother; 2003 Jul; 4(7):1105-19. PubMed ID: 12831337
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to genital warts.
Beutner KR; Ferenczy A
Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660
[TBL] [Abstract][Full Text] [Related]
19. [Imiquimod and immune response modifiers in gynaecology].
Baulon E; Vautravers A; Rodriguez B; Nisand I; Baldauf JJ
Gynecol Obstet Fertil; 2007 Feb; 35(2):149-57. PubMed ID: 17300975
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory and pharmacologic properties of imiquimod.
Sauder DN
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
